Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Cann Group Limited

Investor presentation - Cann Group Limited

ASX:CAN

Cann Group Limited

Health

Cann Group Limited (CAN) is the first Australian company focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company hasestablished research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

Read more

Market Cap

$167.45m

Price at Close

$0.62

4w avg. Volume

2.58m

4w avg. Turnover

$1.68m

Announcements
announcementt+2 movementdate
  • Appendix 2A

    Issued Capital

  • +7.87%

    12 Jan 2021

+7.87%

12 Jan 2021
  • Appendix 3G

    Issued Capital

  • +7.87%

    12 Jan 2021

+7.87%

12 Jan 2021
  • Cann receives $3.2M R&D tax refund

    Progress Report · Market sensitive

  • -3.01%

    07 Jan 2021

-3.01%

07 Jan 2021
  • Strategic investment and European supply order

    Progress Report · Market sensitive

  • +3.33%

    04 Jan 2021

+3.33%

04 Jan 2021
  • First shipment to UK supply partner

    Progress Report · Market sensitive

  • +7.07%

    21 Dec 2020

+7.07%

21 Dec 2020
  • Execution of bank facility documentation

    Periodic Reports · Market sensitive

  • -7.87%

    14 Dec 2020

-7.87%

14 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • -9.93%

    10 Dec 2020

-9.93%

10 Dec 2020
  • Cleansing statement - issue of shares to CSIRO

    Issued Capital

  • +0.98%

    26 Nov 2020

+0.98%

26 Nov 2020
  • Appendix 2A

    Issued Capital

  • +0.98%

    26 Nov 2020

+0.98%

26 Nov 2020
  • Proposed issue of Securities - CAN

    Issued Capital

  • +0.98%

    26 Nov 2020

+0.98%

26 Nov 2020
Market Data

Current Price

$0.62

52WK HIGH

$1.645

52WK LOW

$0.29

1YR RETURN

-59.08%

1YR RETURN VS. SECTOR

-97.76%

90 DAY RETURN

+65.33%

ASX RANK

687

/2,048

SECTOR RANK

59

/168

SHARES OUTSTANDING

270.08m
ASX:CAN

Cann Group Limited

Health

Cann Group Limited (CAN) is the first Australian company focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company hasestablished research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

Read more

Market Cap

$167.45m

Price at Close

$0.62

4w avg. Volume

2.58m

4w avg. Turnover

$1.68m

ASX:CAN is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.